Brady’s FreezerBondz™ Labels Facilitate Virus Research
News Dec 16, 2009
In Cardiff University’s Medical Microbiology Department, frozen cell, virus and plasmid samples are labelled using Brady’s specially developed FreezerBondz™ ID system which withstands long-term low-temperature storage.
Dr Carole Rickards, Laboratory Manager for Infection, Immunity & Biochemistry in the Medical Microbiology Department of Cardiff University, explains the significance of the group’s work: “One of our main projects involves looking at how herpes viruses such as Human Cytomegalovirus (HCMV) manage to evade the immune system and persist in the body following a primary infection.”
“HCMV is the major viral cause of congenital malformation, is associated with life-threatening disease in immunocompromised individuals and is a causative agent of hepatitis, colitis, post-transplantation arteriosclerosis and infectious mononucleosis,” Dr. Rickards continued.
“One of the ways we study this important pathogen is by putting HCMV genes into Adenovirus. Our vast banks of over 800 cell lines stored in liquid nitrogen, as well as frozen plasmid and virus samples at –20 ºC and –70 ºC, together form a vital resource for research. We use Brady’s FreezerBondz™ labels, printed using the BBP11 thermal transfer printer, to ensure that the data for each sample remains legible and intact during long-term storage at low temperatures.”
The BBP11 thermal transfer printer from Brady, the world leader in Identification Solutions, provides fast, economical 300 dpi printing on a wide range of high performance label materials. FreezerBondz™ labels are legible and durable, and can be applied to frozen surfaces including glass and polypropylene stored in liquid nitrogen. Brady’s IdentiLab™ labelling software supports database import and 2D or linear barcoding, while easy-to-use wizards help create new files and templates.
New Inherited Neurodevelopmental Disease DiscoveredNews
Researchers have identified a new inherited neurodevelopmental disease that causes slow growth, seizures and learning difficulties in humans.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018